Enliven Therapeutics (ELVN) Competitors

Enliven Therapeutics (NASDAQ:ELVN) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.

Is ELVN or PTCT more profitable?

Enliven Therapeutics has a net margin of 0.00% compared to PTC Therapeutics' net margin of -50.32%. PTC Therapeutics' return on equity of 0.00% beat Enliven Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enliven Therapeutics	N/A	-29.46%	-27.33%
PTC Therapeutics	-50.32%	N/A	-16.44%

Does the MarketBeat Community prefer ELVN or PTCT?

PTC Therapeutics received 564 more outperform votes than Enliven Therapeutics when rated by MarketBeat users. However, 92.86% of users gave Enliven Therapeutics an outperform vote while only 62.11% of users gave PTC Therapeutics an outperform vote.

Company	Underperform	Outperform
Enliven Therapeutics	Outperform Votes 13 92.86%	Underperform Votes 1 7.14%
PTC Therapeutics	Outperform Votes 577 62.11%	Underperform Votes 352 37.89%

Does the media refer more to ELVN or PTCT?

In the previous week, Enliven Therapeutics had 7 more articles in the media than PTC Therapeutics. MarketBeat recorded 23 mentions for Enliven Therapeutics and 16 mentions for PTC Therapeutics. PTC Therapeutics' average media sentiment score of 0.78 beat Enliven Therapeutics' score of 0.40 indicating that PTC Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enliven Therapeutics	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
PTC Therapeutics	10 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of ELVN or PTCT?

95.1% of Enliven Therapeutics shares are held by institutional investors. 29.2% of Enliven Therapeutics shares are held by insiders. Comparatively, 5.5% of PTC Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has higher earnings and valuation, ELVN or PTCT?

Enliven Therapeutics has higher earnings, but lower revenue than PTC Therapeutics. Enliven Therapeutics is trading at a lower price-to-earnings ratio than PTC Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enliven Therapeutics	N/A	N/A	-$71.58M	-$1.92	-8.73
PTC Therapeutics	$1.77B	2.04	-$626.60M	$6.51	6.99

Which has more risk and volatility, ELVN or PTCT?

Enliven Therapeutics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Do analysts rate ELVN or PTCT?

Enliven Therapeutics currently has a consensus price target of $37.25, indicating a potential upside of 122.12%. PTC Therapeutics has a consensus price target of $63.25, indicating a potential upside of 38.95%. Given Enliven Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Enliven Therapeutics is more favorable than PTC Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enliven Therapeutics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
PTC Therapeutics	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.64

Summary

Enliven Therapeutics beats PTC Therapeutics on 9 of the 17 factors compared between the two stocks.